Expert insight:

Video: Interview with CELforPharma faculty member, Gary Johnson, on the 4 payer types to be considered in optimising value pricing in pharma.


Payer research is critical to set the right price for a new pharmaceutical, but there is no such thing as THE payer. Watch the below 2-min video interview with Gary Johnson, expert faculty member teaching CELforPharma’s 2-day Value Pricing for Optimising Market Access course, who explains the different types of payers you need to consider before starting your pricing research.

Gary Johnson is a thought leader in this respect since he has been involved in pricing for around half of the new molecular entity launches over the past 5 years and is the author of Value Pricing for Market Access: Evidence-Based Pricing for Pharmaceuticals.

Last update: October 2021

 

➤ More info on the 'Value Pricing for Optimising Market Access' course

➤ More info on other Market Access, Pricing & Health Economics courses